Pantoprazole Sodium
Brand name: Pantoprazole Sodium
Rank #110 of 500 drugs by total cost
$165.1M
Total Cost
10,061,854
Total Claims
$165.1M
Total Cost
127,427
Prescribers
$16
Cost per Claim
2,945,581
Beneficiaries
20,690,241
30-Day Fills
$1,296
Avg Cost/Provider
79
Avg Claims/Provider
About Pantoprazole Sodium
Pantoprazole Sodium (sold as Pantoprazole Sodium) was prescribed 10,061,854 times by 127,427 Medicare Part D providers in 2023, costing the program $165.1M. At $16 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 107 | Sucroferric Oxyhydroxide (Velphoro) | $166.8M | 54,837 |
| 108 | Lifitegrast (Xiidra) | $166.6M | 149,269 |
| 109 | Alirocumab (Praluent Pen) | $165.6M | 203,805 |
| 110 | Pantoprazole Sodium (Pantoprazole Sodium) | $165.1M | 10,061,854 |
| 111 | Lenvatinib Mesylate (Lenvima) | $164.6M | 7,004 |
| 112 | Treprostinil (Tyvaso Dpi) | $158.9M | 6,704 |
| 113 | Rimegepant Sulfate (Nurtec Odt) | $155.0M | 106,692 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology